RDI Group

RDi Group is a global leader in healthcare and pharmaceutical services, specializing in the design, manufacture, and fulfillment of complex diagnostic kitting and patient sample collection solutions. The company operates through three core divisions: RDi Health, which delivers self-sampling and in-clinic kits; RDi Evolve, which provides data-driven operational insights; and RDi Connect, which manages secure fulfillment and communications. RDi Group is recognized for its expertise in UN3373-compliant packaging and its proprietary +Cura digital platform, which connects patients, providers, and laboratories in real-time to streamline the diagnostic journey. With a focus on automation and data-led customization, the company supports large-scale public health initiatives, including the NHS Bowel Cancer Screening program, and serves a diverse international client base of healthcare providers, research organizations, and insurers.